| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |